Nitroglycerin Infusion During Cardiac Surgery
Information source: Tri-Service General Hospital
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Lactic Acidosis; Bleeding
Intervention: Nitroglycerin infusion (Drug)
Phase: N/A
Status: Recruiting
Sponsored by: Tri-Service General Hospital Official(s) and/or principal investigator(s): Tso-Chou Lin, MD, Principal Investigator, Affiliation: Tri-Service General Hospital
Overall contact: Tso-Chou Lin, MD, Phone: +886287923311, Ext: 12907, Email: tclin@ndmctsgh.edu.tw
Summary
Hypothermic cardiopulmonary bypass results in peripheral vasoconstriction and heparin
trapping. Hypoperfusion and ischemic-reperfusion injury are associated with systemic
inflammatory response, while insufficient and delayed neutralization of heparin by protamine
may contribute to more blood loss during rewarming stage.
Nitroglycerin infusion, an NO-related vasodilator, is an established and effective treatment
for unstable angina, myocardial infarction, congestive heart failure, and perioperative
hemodynamic management for cardiac surgery. Therefore, we hypothesize that nitroglycerin
infusion during rewarming corrects systemic ischemic stress and facilitates heparin
neutralization in cardiac surgery.
Clinical Details
Official title: Nitroglycerin Infusion During Rewarming in Cardiac Surgery and Its Effects on Tissue Perfusion and Coagulation
Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Supportive Care
Primary outcome: Plasma lactate levelPerioperative blood loss
Secondary outcome: Mean arterial blood pressureInotropic doses Time to extubation
Detailed description:
A randomized clinical trial in a tertiary academic center in patients with cardiac surgery,
to receive either nitroglycerin infusion dose of 0-0. 1 mcg/kg/min, or 1-5 mcg/kg/min during
rewarming in cardiopulmonary bypass.
Eligibility
Minimum age: 20 Years.
Maximum age: 80 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- elective cardiac surgery
Exclusion Criteria:
- heart failure, respiratory failure, asthma attack, uremia.
Locations and Contacts
Tso-Chou Lin, MD, Phone: +886287923311, Ext: 12907, Email: tclin@ndmctsgh.edu.tw
Tri-Service General Hospital, Taipei 114, Taiwan; Recruiting Tso-Chou Lin, Phone: +886287923311, Ext: 12907, Email: tclin@ndmctsgh.edu.tw Tso-Chou Lin, MD, Principal Investigator
Additional Information
Related publications: Piquette D, Deschamps A, Bélisle S, Pellerin M, Levesque S, Tardif JC, Denault AY. Effect of intravenous nitroglycerin on cerebral saturation in high-risk cardiac surgery. Can J Anaesth. 2007 Sep;54(9):718-27. Masoumi G, Pour EH, Sadeghpour A, Ziayeefard M, Alavi M, Anbardan SJ, Shirani S. Effect of different dosages of nitroglycerin infusion on arterial blood gas tensions in patients undergoing on- pump coronary artery bypass graft surgery. J Res Med Sci. 2012 Feb;17(2):123-7.
Starting date: July 2013
Last updated: July 13, 2013
|